Tan et al. showed significant inhibition of FOXM1 suppressed MDA-MB-231 cell tumorigenesis in in vivo [42], and silencing of FOXM1 enhanced sensitivity to cisplatin, Dox, and paclitaxel in several cancers and induced cell death [43,44]. Here, FOXM1 is linked to cancer.